📅 PUBMED DAILY TRIAGE — 2026-05-16
Window: 2026-05-15T09:00:00Z → 2026-05-16T09:00:00Z (CRDT)
Topics scanned: 10 | Candidates reviewed: ~90 | Articles classified: 17
High priority: 6 | Standard: 10 | Low/archive: ~55+ | Unsolicited finds: 1
Run status: ✅ SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Genomics/Precision Medicine + Rare Diseases
TR-2026-05-16-001 / PMID 42141198 · Population-scale genomic medicine with the Hong Kong Genome Project · 9/10 🟠
Nature Medicine. 20,000+ participants; 25% rare disease diagnostic yield; 38 genes missing from European panels critical for Chinese population; near-universal pharmacogenomic actionability. Blueprint for precision medicine in underrepresented populations.
CBC-based Diagnostics + AI/ML
TR-2026-05-16-002 / PMID 42141020 · CytologIA: Multicentric AI challenge for leukocyte classification · 9/10 🟢
NPJ Precis Oncol. 69,168 images, 23 leukocyte classes, 245 teams, 20 labs (France/Belgium/Switzerland). Best model: YOLOX + transformer ensemble, balanced accuracy 0.94. Open data/code release on data.gouv.fr — first large-scale reproducible AI benchmark in hematological morphology.
Cardiovascular-Metabolic: GLP-1, SGLT2
TR-2026-05-16-003 / PMID 42141180 · GLP-1RA and GLP-1RA/GIP dual agonists on liver stiffness/steatosis (meta-analysis) · 8/10 🟢
Meta-analysis: 5 studies/9 trials, N=554 treated. GLP-1 agents significantly improved liver stiffness (SMD=-0.3, p=0.02) and steatosis (SMD=-0.4, p=0.03) by Fibroscan. Extends incretin evidence beyond glycemia into MASLD endpoints.
TR-2026-05-16-004 / PMID 42141141 · SGLT-2 inhibitors on epicardial adiposity and LV function in Asian T2DM+CAD · 8/10 🟢
Prospective cohort, N=302, Malaysia. SGLT-2i reduced EAT -1.5mm vs +0.6mm control (p<0.001); improved LV ejection fraction +4.6% vs -1.0%. Asian population-specific evidence; EAT reduction independent of glycemic changes.
Hematologic Malignancies + Novel Therapeutics
TR-2026-05-16-005 / PMID 42141373 · CD19/BCMA CAR-T for anti-HLA desensitization in AML/B-ALL before HSCT (pilot) · 8/10 🟠
Pilot study, N=7 (4 AML, 3 B-ALL). 71% showed anti-HLA-I MFI decrease; DSA median MFI 15,797→3,831 (p<0.001); 86% CAR-T expansion; no grade ≥3 CRS/neurotoxicity. Novel application solving a critical transplant barrier — validates concept requiring larger study.
AI/ML in Diagnostics + Precision Oncology
TR-2026-05-16-006 / PMID 42141326 · HESpotEx: dual-stream deep learning for spatial gene expression from histological images · 8/10 ⚪
Nature Computational Science. Predicts up to 5,457 genes at spot level from routine WSI slides — a low-cost alternative to spatial transcriptomics. Validated on TCGA + multiple cancer types including lymphoma. Alert suppressed (cap reached).
🟢⚪ STANDARD (5–7) — Top by Topic
AI/ML in Diagnostics
- TR-2026-05-16-007 / 42141332 · MRI+NLP multimodal model for cervical cancer stromal invasion (AUC 0.912) · 7/10 · Diagnostics (external validation n=20 — preliminary)
- TR-2026-05-16-009 / 42141418 · Plasma proteomics+ML for pneumoconiosis grading; PRSS3 AUC=1.00 training · 7/10 · Diagnostics (overfitting concern, small N=158)
- TR-2026-05-16-010 / 42141301 · Explainable ML for MASLD screening using routine labs (AUC 0.879/0.822 US+Korea) · 7/10 · Diagnostics
Early Cancer Detection / Health Equity
- TR-2026-05-16-008 / 42141357 · SDoH racial disparities in 1,831 GI cancer patients (All of Us); food insecurity 23.6% vs 5.8%, delayed care 47.1% vs 26.8% · 7/10 · Public Health 🟡 UNDERSERVED
- TR-2026-05-16-014 / 42141388 · Scoping review: false-positive stool tests for CRC; 0-4.3% non-colorectal cancer; standardized reporting needed · 6/10 · Early Detection
Aging & Neurodegeneration
- TR-2026-05-16-012 / 42141167 · Aging-RAGE mechanism drives breast cancer metastasis (mouse + TCGA human correlate) · 7/10 · Drug Development
- TR-2026-05-16-011 / 42141233 · Mixed neuropathologies in Down syndrome: CAA 84%, pure ADNC only 29%; resilience phenotype identified · 7/10 · Other 🟡 UNDERSERVED
- TR-2026-05-16-015 / 42141120 · LATE-NC: biomarker development review; affects 1/3 of 80+ year olds; no in-vivo diagnostic yet · 6/10 · Diagnostics
Hematologic Malignancies
- TR-2026-05-16-013 / 42141360 · BCMA CAR-T safety review in myeloma: CRS, ICANS, parkinsonian events, HLH, secondary malignancies · 6/10 · Treatment Innovation
Cardiovascular-Metabolic
- TR-2026-05-16-016 / 42141317 · Allurion gastric balloon, N=300 Ecuador; TWL 14.4% at 12 months; Latin American real-world data · 6/10 · Treatment Innovation 🟡 UNDERSERVED
💡 UNSOLICITED FINDS
- TR-2026-05-16-S01 / PMID 42141498 · Prone positioning response definitions in ARDS: meta-analysis · 5/10 · Crit Care — 68% oxygenation responders; heterogeneous definitions; survival link weak. Out-of-watchlist. Not pipeline-forwarded.
📊 TODAY'S BREAKDOWN
By research category:
- Diagnostics: 5 articles
- Treatment Innovation: 4 articles
- Genomics/Precision Medicine: 2 articles
- Public Health: 2 articles
- Drug Development: 1 article
- Early Detection: 1 article
- Other: 2 articles
By evidence maturity:
- Validated: 5 articles
- Exploratory: 11 articles
- Potentially Practice-Changing: 0
By watchlist topic (reviewed / kept / highest score):
| Topic | Reviewed | Kept | Best Score |
|---|---|---|---|
| Hematologic malignancies | 10 | 2 | 8 (PMID 42141373) |
| CBC/ML in hematology | 10 | 2 | 9 (PMID 42141020) |
| Early cancer detection | 10 | 2 | 7 (PMID 42141357) |
| AI/ML diagnostics | 10 | 4 | 9 (PMID 42141020) |
| Precision oncology | 10 | 3 | 9 (PMID 42141198) |
| Novel therapeutics (immunotherapy/CAR-T) | 10 | 2 | 8 (PMID 42141373) |
| Cardiovascular-metabolic (GLP-1/SGLT2) | 10 | 3 | 8 (PMID 42141180) |
| Aging/longevity | 10 | 4 | 7 (PMID 42141167) |
| Rare diseases | 10 | 2 | 9 (PMID 42141198) |
| Sentinel scan | 10 | 1 | 5 (PMID 42141498) |
By source type: Peer-reviewed: 17 | Preprint: 0
Topics with zero 8+ articles this run: Early cancer detection (liquid biopsy/ctDNA), Aging/longevity (best: 7/10)
🔧 RUN NOTES
- humans[MeSH] filter restored for Aging/longevity topic as planned from 2026-05-15 run note. Result: 40 hits (vs. expected 50+ without filter) — filter successfully reduced non-human noise.
- Rare diseases streak broken: PMID 42141198 (HKGP, Nat Med) scored 9/10 HIGH for both Rare Diseases and Precision Oncology topics. Prior 3-run zero-standard streak ended.
- Alert cap reached at 5: TR-2026-05-16-006 (HESpotEx, PMID 42141326, score 8/10) alert suppressed due to cap. Article retained for pipeline handoff.
- AUC=1.00 flag: PMID 42141418 (PRSS3 pneumoconiosis) reports training AUC=1.00 — annotated as likely overfitting; classification_confidence set to medium.
- Window: Full 24-hour incremental CRDT window retrieved as expected.
- Rolling 7-day view: Early cancer detection has produced no HIGH articles in the last 3 runs (best score: 7/10). Recommend broadening this query next run to include "multicancer early detection" and "MCED" terms.
- No partial failures, no NCBI API errors encountered.